IMC-2018 Learning Session 38:48

by Joseph Tyska, Bristol-Myers Squibb

Bristol-Myers Squibb (BMS) focuses on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. BMS is a pioneering organization in the field of immuno-oncology, harnessing the power of a person's immune system to help fight cancer. At the BMS Hopewell Clinical Manufacturing (HCM) facility, immuno-oncology (IO) drug substances are manufactured for first in human clinical trials. Sixty percent of the company's IO pipeline is manufactured in HCM. At HCM, biologics drug substance involves the growth of host cells to produce the protein drug substance. Once the growth process is started, it cannot be stopped until final harvest when the protein medicines are extracted from the host cells. The cell growth process is a 24/7 operation for approximately 28 days. HCM has two production wings, with multiple concurrent campaigns. Reliable production and support equipment is critical to BMS success. All of the HCM production activities conducted under current Good Manufacturing Practices (cGMP) and subject to FDA scrutiny. Once every 18 months production activities are shutdown to address critical utility system preventive maintenance needs. During this shutdown period, all capital and expense reliability, sustainability, and environmental projects delayed by production schedules are simultaneously executed. This presentation captures the planning, scope, and lessons learned from the 2016 HCM shutdown, spending $4MM+ in six weeks and return to service of clinical manufacturing production.

Upcoming Events

August 9 - August 11 2022

MaximoWorld 2022

View all Events
banner
80% of Reliabilityweb.com newsletter subscribers report finding something used to improve their jobs on a regular basis.
Subscribers get exclusive content. Just released...MRO Best Practices Special Report - a $399 value!
DOWNLOAD NOW
Project Planning and Management for Asset Recapitalization and Enhancement with Maximo

Project Planning and Management for Asset Recapitalization and Enhancement with Maximo

Being part of an O&M organization means not only dealing with the day-to-day asset maintenance but planning for the recapitalizations and enhancements that will keep the capabilities of the facility current for years to come.

I Need Reliability, but How Do I Talk to My Senior Leaders?

I Need Reliability, but How Do I Talk to My Senior Leaders?

Not managing your assets to deliver true reliability? How do you get started and get Senior Leaders engaged in the effort?

Framatome's Innovative Use of Maximo to Support the Nuclear Power Industry

Framatome's Innovative Use of Maximo to Support the Nuclear Power Industry

Framatome is an international leader in nuclear energy recognized for its innovative solutions and value-added technologies for the global nuclear fleet.

A Robust Framework for Risk Management

A Robust Framework for Risk Management

Asset management is the coordinated activities of an organization to realize value from assets. Guidance in asset management can be found in the ISO 5500X series of international standards.